Appetite Hormones in Binge Eating Disorder

NCT01552759 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2013-03-11

No results posted yet for this study

Summary

This study investigates the hormones that the body produces in response to food intake and in response to stress, and the way that stress influences food intake. In particular, it compares the hormone levels and food intake of people with and without binge eating disorder. In order to find out how these appetite- and stress-related hormones are linked to brain activity, the study also includes an fMRI scan, a non-invasive procedure that looks at which regions of the brain are most active during a food-related scenario.

Conditions

  • Binge Eating Disorder

Interventions

PROCEDURE

Postprandial responses

Subjects ingest a fixed meal, with blood draws to measure appetite hormone levels taken before and after the meal.

BEHAVIORAL

Cold pressor test

Subjects then undergo the Socially-Evaluated Cold Pressor Test, with blood draws to measure appetite hormone levels taken before and after the test.

BEHAVIORAL

Test meal

Subjects are presented with an ad libitum buffet meal.

Sponsors & Collaborators

  • St. Luke's-Roosevelt Hospital Center

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • New York Obesity and Nutrition Research Center

    lead OTHER

Principal Investigators

  • Allan Geliebter, PhD · New York Obesity and Nutrition Research Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01552759 on ClinicalTrials.gov